SCHEMBL12003129

SCHEMBL12003129

CCCCC#Cc1nc(N)c2ncn(C3C[C@H](NC(=O)CC)[C@@H](O)C3OC(=O)C(F)(F)F)c2n1

nearest known ligand 0.77

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 13/20 0.77
ADORA3 P0DMS8 8/20 0.77
ADORA2B P29275 7/20 0.51
ADORA1 P30542 2/20 0.51
ALDH1A1 P00352 1/20 0.50
GLA P06280 1/20 0.50
PMP22 Q01453 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4220368 1.00 ADORA2A (0.77) ADORA2AADORA3ADORA2BADORA1ALDH1A1
SCHEMBL2093019 1.00 ADORA2A (0.77) ADORA2AADORA3ADORA2BADORA1ALDH1A1
Trifluoroacetic Acid SCHEMBL1401969 0.88 ADORA2A (0.89) ADORA2AADORA3ADORA2BADORA1ALDH1A1
SCHEMBL2089933 0.84 ADORA3 (0.52) ADORA2AADORA3ADORA1SMN1; SMN2
SCHEMBL239969 0.84 ADORA3 (0.52) ADORA2AADORA3ADORA1SMN1; SMN2
SCHEMBL592233 0.82 ADORA2A (0.54) ADORA2AADORA3ADORA2BADORA1ALDH1A1
SCHEMBL592232 0.81 ADORA2A (0.55) ADORA2AADORA3ADORA2BADORA1ALDH1A1
SCHEMBL1402078 0.78 ADORA2A (0.51) ADORA2AADORA3ADORA2BADORA1
SCHEMBL2088729 0.78 ADORA2A (0.51) ADORA2AADORA3ADORA2BADORA1
SCHEMBL1401963 0.77 ADORA2A (0.59) ADORA2AADORA3ADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805181-B1 PURINE DERIVATIVES FOR USE AS ADENOSIN A-2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2012-08-29 EP disclosed